Top

Published in:

07-07-2023 | Cystectomy | Topic Paper

Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer

Authors: Peace Orji, Helen Sun, Ilaha Isali, Spencer Bell, Nicholas Zaorsky, Kirtishri Mishra, Shubham Gupta, Andres Correa, Marc Smaldone, Adam Calaway, Rosalia Viterbo, Laura Bukavina

Published in: World Journal of Urology | Issue 7/2023

Abstract

RC significantly negatively impacts sexual function (SF) in both men and women. While significant research resources have been allocated to examine the deleterious effects of post prostatectomy erectile dysfunction, little attention has been directed towards female sexual function and organ preservation post cystectomy. These academic shortcomings often result in poor provider awareness and inadequate preoperative assessment. As such, it is crucial for all providers involved in female RC care to understand the necessary and available tools for preoperative evaluation, in addition to the anatomic and reconstructive techniques. This review aims to summarize the current preoperative evaluation and available tools of SF assessment and describe in detail the varying operative techniques in the preservation or restoration of SF in women after RC. The review explores the intricacies of preoperative evaluation tools, and intraoperative techniques for organ- and nerve-sparing during radical cystectomy in females. Particular emphasis on vaginal reconstruction after partial or complete resection is provided, including split-thickness skin (STF) graft vaginoplasy, pedicled flaps, myocutaneous flaps and use of bowel segments. In conclusion, this narrative review highlights the importance of understanding anatomic considerations and nerve-sparing strategies in promoting postoperative SF and quality of life. Furthermore, the review describes the advantages and limitations of each organ- and nerve-sparing technique and their impact on sexual function and overall well-being.

Bladder Cancer — Cancer Stat Facts. Accessed October 26, 2022. https://seer.cancer.gov/statfacts/html/urinb.html

Dobruch J, Daneshmand S, Fisch M et al (2016) Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol 69(2):300–310. https://doi.org/10.1016/J.EURURO.2015.08.037CrossRefPubMed

Bukavina L, Prunty M, Mishra K et al (2021) Gender disparities in bladder cancer-specific survival in high poverty areas utilizing Ohio cancer incidence surveillance system (OCISS). Urology 151:163–168. https://doi.org/10.1016/j.urology.2020.07.013CrossRefPubMed

Chang SS, Bochner BH, Chou R et al (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol 198(3):552–559. https://doi.org/10.1016/j.juro.2017.04.086CrossRefPubMedPubMedCentral

Chang SS, Boorjian SA, Chou R et al (2016) Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol 196(4):1021–1029. https://doi.org/10.1016/j.juro.2016.06.049CrossRefPubMed

Barocas DA, Alvarez JA, Resnick MJ et al (2017) Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA 317(11):1126–1140. https://doi.org/10.1001/JAMA.2017.1704CrossRefPubMedPubMedCentral

Chen RC, Basak R, Meyer AM et al (2017) Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317(11):1141–1150. https://doi.org/10.1001/JAMA.2017.1652CrossRefPubMedPubMedCentral

Voigt M, Hemal K, Matthews C (2019) Influence of simple and radical cystectomy on sexual function and pelvic organ prolapse in female patients: a scoping review of the literature. Sex Med Rev 7(3):408–415. https://doi.org/10.1016/J.SXMR.2019.03.005CrossRefPubMed

Modh RA, Mulhall JP, Gilbert SM (2014) Sexual dysfunction following cystectomy and urinary diversion. Nat Rev Urol 11(8):445. https://doi.org/10.1038/NRUROL.2014.151CrossRefPubMedPubMedCentral

10.

Hatzichristou D, Kirana PS, Banner L et al (2016) Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires. J Sex Med 13(8):1166–1182. https://doi.org/10.1016/J.JSXM.2016.05.017CrossRefPubMed

11.

Avulova S, Wittmann D (2021) Optimizing women’s sexual function and sexual experience after radical cystectomy. Urology 151:138–144. https://doi.org/10.1016/J.UROLOGY.2020.08.019CrossRefPubMed

12.

Hevesi K, Mészáros V, Kövi Z, Márki G, Szabó M (2017) Different characteristics of the female sexual function index in a sample of sexually active and inactive women. J Sex Med 14(9):1133–1141. https://doi.org/10.1016/J.JSXM.2017.07.008CrossRefPubMed

13.

Mor MK, Sevick MA, Shields AM et al (2014) Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol 9(1):128–134. https://doi.org/10.2215/CJN.05470513CrossRefPubMed

14.

Porter MP, Penson DF (2005) Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol 173(4):1318–1322. https://doi.org/10.1097/01.JU.0000149080.82697.65CrossRefPubMed

15.

Månsson Å, Davidsson T, Hunt S, Månsson W (2002) The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: Is there a difference? BJU Int 90(4):386–390. https://doi.org/10.1046/J.1464-410X.2002.02899.XCrossRefPubMed

16.

Cookson MS, Dutta SC, Chang SS, Clark T, Smith JA, Wells N (2003) Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol 170(5):1926–1930. https://doi.org/10.1097/01.JU.0000092830.03247.EFCrossRefPubMed

17.

Gilbert SM, Dunn RL, Hollenbeck BK et al (2010) Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. J Urol 183(5):1764–1770. https://doi.org/10.1016/J.JURO.2010.01.013CrossRefPubMed

18.

Erber B, Schrader M, Miller K et al (2012) Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder. ISRN Urol 2012:1–8. https://doi.org/10.5402/2012/342796CrossRef

19.

Flynn KE, Lin L, Cyranowski JM et al (2013) Development of the NIH PROMIS^® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med 10(Suppl 1):43–52. https://doi.org/10.1111/J.1743-6109.2012.02995.XCrossRefPubMedPubMedCentral

20.

Veskimäe E, Neuzillet Y, Rouanne M et al (2017) Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int 120(1):12–24. https://doi.org/10.1111/BJU.13819CrossRefPubMed

21.

An J, Hifren LS, Lenn G et al (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New Eng J Med 343(10):682–688. https://doi.org/10.1056/NEJM200009073431002CrossRef

22.

Davis L, Isali I, Prunty M et al (2022) Female sexual function following radical cystectomy in bladder cancer. Sex Med Rev 10(2):231–239. https://doi.org/10.1016/J.SXMR.2021.10.005CrossRefPubMed

23.

Horenblas S, Meinhardt W, Ijzerman W, Moonen LFM (2001) Sexuality preserving cystectomy and neobladder: initial results. J Urol 166(3):837–840. https://doi.org/10.1016/S0022-5347(05)65847-8CrossRefPubMed

24.

Niver BE, Daneshmand S, Satkunasivam R (2015) Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes. Curr Opin Urol 25(2):105–110. https://doi.org/10.1097/MOU.0000000000000146CrossRefPubMed

25.

Van Winden LJ, Vermeulen RFM, Van Den Noort V et al (2022) Changes in sex steroids and relation with menopausal complaints in women undergoing risk-reducing Salpingo-oophorectomy. J Endocr Soc 6(6):1–11. https://doi.org/10.1210/JENDSO/BVAC069CrossRef

26.

Liedberg F, Jancke G, Sörenby A, Kannisto P (2017) Should we refrain from performing oophorectomy in conjunction with radical cystectomy for bladder cancer? Eur Urol 71(6):851–853. https://doi.org/10.1016/J.EURURO.2016.10.010CrossRefPubMed

27.

Witjes JA, Bruins HM, Cathomas R et al (2021) European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79(1):82–104. https://doi.org/10.1016/J.EURURO.2020.03.055CrossRefPubMed

28.

Avulova S, Chang SS (2018) Role and indications of organ-sparing “radical” cystectomy the importance of careful patient selection and counseling. Urol Clin North Am. https://doi.org/10.1016/j.ucl.2017.12.005CrossRefPubMed

29.

Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615. https://doi.org/10.1056/nejmoa020119CrossRefPubMed

30.

Ali-El-Dein B, Gomha M, Ghoneim MA (2002) Critical evaluation of the problem of chronic urinary retention after orthotopic bladder substitution in women. J Urol 168(2):587–592. https://doi.org/10.1016/S0022-5347(05)64685-XCrossRefPubMed

31.

Tung N, Domchek SM, Stadler Z et al (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13(9):581–588. https://doi.org/10.1038/NRCLINONC.2016.90CrossRefPubMedPubMedCentral

32.

Liu YL, Breen K, Catchings A et al (2022) Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes. JCO Oncol Pract 18(3):201–209. https://doi.org/10.1200/OP.21.00382CrossRefPubMed

33.

Wong J, Murji A, Sunderji Z et al (2020) Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation. Menopause 28(1):8–11. https://doi.org/10.1097/GME.0000000000001652CrossRefPubMed

34.

Vosoughi A, Zhang T, Shohdy KS et al (2020) Common germline-somatic variant interactions in advanced urothelial cancer. Nat Commun 11(1):1–13. https://doi.org/10.1038/s41467-020-19971-8CrossRef

35.

Johansen N, Liavaag AH, Mørkrid L, Michelsen TM (2018) Hormone levels and sexual functioning after risk-reducing salpingo-oophorectomy. Sex Med 6(2):143–153. https://doi.org/10.1016/J.ESXM.2018.02.002CrossRefPubMedPubMedCentral

36.

Tuesley KM, Protani MM, Webb PM et al (2020) Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol 223(5):723.e1-723.e16. https://doi.org/10.1016/J.AJOG.2020.04.037CrossRefPubMed

37.

Kotsopoulos J, Shafrir AL, Rice M et al (2015) The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women. Horm Cancer 6(1):54–63. https://doi.org/10.1007/S12672-014-0209-7/TABLES/3CrossRefPubMed

38.

Manchanda R, Legood R, Pearce L, Menon U (2015) Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. Gynecol Oncol 139(3):487–494. https://doi.org/10.1016/J.YGYNO.2015.10.001CrossRefPubMed

39.

Drohan B, Roche CA, Cusack JC, Hughes KS (2012) Hereditary breast and ovarian cancer and other hereditary syndromes: Using technology to identify carriers. Ann Surg Oncol 19(6):1732–1737. https://doi.org/10.1245/S10434-012-2257-Y/FIGURES/2CrossRefPubMed

40.

Vitonis AF, Titus-Ernstoff L, Cramer DW (2011) Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy. Obstet Gynecol 117(5):1042–1050. https://doi.org/10.1097/AOG.0B013E318212FCB7CrossRefPubMedPubMedCentral

41.

Manchanda R, Gaba F, Talaulikar V et al (2022) Risk-reducing salpingo-oophorectomy and the use of hormone replacement therapy below the age of natural menopause. BJOG An Int J Obstet Gynaecol 129(1):e16–e34. https://doi.org/10.1111/1471-0528.16896CrossRef

42.

Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S (2012) Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. J Urol 188(6):2134–2138. https://doi.org/10.1016/J.JURO.2012.08.024CrossRefPubMed

43.

Johnson RJ, Carrington BM, Jenkins JPR, Barnard RJ, Read G, Isherwood I (1990) Accuracy in staging carcinoma of the bladder by magnetic resonance imaging. Clin Radiol 41(4):258–263. https://doi.org/10.1016/S0009-9260(05)81661-7CrossRefPubMed

44.

Bi Q, Chen Y, Wu K et al (2020) The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: a meta-analysis. Acad Radiol 27(7):960–968. https://doi.org/10.1016/J.ACRA.2019.09.018CrossRefPubMed

45.

Zhang W, Chen C, Liu P et al (2019) Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer. Cancer Manag Res 11:3603. https://doi.org/10.2147/CMAR.S197496CrossRefPubMedPubMedCentral

46.

Unlu E, Virarkar M, Rao S, Sun J, Bhosale P (2020) Assessment of the effectiveness of the vaginal contrast media in magnetic resonance imaging for detection of pelvic pathologies: a meta-analysis. J Comput Assist Tomogr 44(3):436–442. https://doi.org/10.1097/RCT.0000000000001012CrossRefPubMed

47.

Stein JP, Stenzl A, Esrig D et al (1994) Lower urinary tract reconstruction following cystectomy in women using the Kock ileal reservoir with bilateral ureteroileal urethrostomy: initial clinical experience. J Urol 152(5 Pt 1):1404–1408. https://doi.org/10.1016/S0022-5347(17)32431-XCrossRefPubMed

48.

Stenzl A, Colleselli K, Poisel S, Feichtinger H, Pontasch H, Bartsch G (1995) Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol 154(6):2044–2049. https://doi.org/10.1016/S0022-5347(01)66688-6CrossRefPubMed

49.

Volkmer BG, Gschwend JE, Herkommer K, Simon J, Küfer R, Hautmann RE (2004) Cystectomy and orthotopic ileal neobladder: the impact on female sexuality. J Urol 172(6 Pt 1):2353–2357. https://doi.org/10.1097/01.JU.0000145190.84531.66CrossRefPubMed

50.

Metzler T. Vaginoplasty procedures, complications and aftercare. UCSF TRansgender Care & Treatment Guidelines. https://transcare.ucsf.edu/guidelines/vaginoplasty

51.

Bizic M, Kojovic V, Duisin D et al (2014) An overview of neovaginal reconstruction options in male to female rranssexuals. Sci World J. https://doi.org/10.1155/2014/638919CrossRef

52.

Cordeiro PG, Pusic AL, Disa JJ (2002) A classification system and reconstructive algorithm for acquired vaginal defects. Plast Reconstr Surg 110(4):1058–1065. https://doi.org/10.1097/01.PRS.0000020988.13244.A0CrossRefPubMed

53.

McIndoe A (1950) The treatment of congential abscence and obliterative conditions of the vagina. Br J Plast Surg 2(4):254–267PubMed

54.

Kirschner M, Wagner G (1930) Ein neues Verfahren der künstlichen Schreidenbildung. Zentralbl Gynakol 54(2690). https://doi.org/10.1016/S0002-9378(36)90979-1

55.

Linder BJ, Gebhart JB (2020) McIndoe neovagina creation for the management of vaginal agenesis. Int Urogynecol J 32(2):453–455. https://doi.org/10.1007/S00192-020-04425-YCrossRefPubMed

56.

Klingele CJ, Gebhart JB, Croak AJ et al (2003) McIndoe procedure for vaginal agenesis: long-term outcome and effect on quality of life. Am J Obstet Gynecol 189(6):1569–1572. https://doi.org/10.1016/S0002-9378(03)00938-4CrossRefPubMed

57.

Jagadeb SO, Bisoi MCh S (2023) Long term outcome of mcindoe’s technique for vaginal agenesis & effect on quality of life, sexual function & body image. Int J Sci Res ISSN 4(4):2960–2963. www.ijsr.net. (Accessed Apr 10, 2023)

58.

Sadove RC, Horton CE (1988) Utilizing full-thickness skin grafts for vaginal reconstruction. Clin Plast Surg 15(3):443–448. https://doi.org/10.1016/S0094-1298(20)31421-8CrossRefPubMed

59.

Hatch KD (1984) Construction of a neovagina after exenteration using the vulvobulbocavernosus myocutaneous graft. Bstetrics Gynecol 63(1):110–114

60.

Crawley WA, Grumbine FC, Dorsey JH (1994) Flap reconstruction of the stenotic vagina. J Am Coll Surg 178(1):47–48PubMed

61.

Elaffandi AH, Khalil HH, Aboul Kassem HA, El Sherbiny M, El Gemeie EH (2007) Vaginal reconstruction with a greater omentum–pedicled graft combined with a vicryl mesh after anterior pelvic exenteration. Surgical approach with long-term follow-up. Int J Gynecol Cancer. 17(2):536–542. https://doi.org/10.1111/J.1525-1438.2007.00842.XCrossRefPubMed

62.

Crosby MA, Hanasono MM, Feng L, Butler CE (2011) Outcomes of partial vaginal reconstruction with pedicled flaps following oncologic resection. Plast Reconstr Surg 127(2):663–669. https://doi.org/10.1097/PRS.0B013E3181FED5F3CrossRefPubMed

63.

Mccraw JB, Massey FM, Shanklin KD, Horton CE (1976) Vaginal reconstruction with gracilis myocutaneous flaps. Plastic Reconstruct Surg 58(2):176–183CrossRef

64.

Cain JM, Diamond ANGELA, Tamimi HK, Greer BE, Figge DC (1989) The morbidity and benefits of concurrent gracilis myocutaneous graft with pelvic exenteration. Obstet Gynecol 74(2):185–189PubMed

65.

Esrig D, Freeman JA, Stein JP, Elmajian DA, Lytton B, Skinner DG (1997) New technique of vaginal reconstruction following anterior exenteration. Urology 49(5):768–771. https://doi.org/10.1016/S0090-4295(97)00089-7CrossRefPubMed

66.

Chen Z, Chen M, Chen C, Wu N (1989) Vaginal reconstruction with an axial subcutaneous pedicle flap from the inferior abdominal wall. Plast Reconstr Surg 26(83):1005–1012CrossRef

67.

Gakis G, Efstathiou J, Lerner SP et al (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 63(1):45–57. https://doi.org/10.1016/J.EURURO.2012.08.009CrossRefPubMed

68.

Pratt JHM (1972) Vaginal atresia corrected by use of small and large bowel. Clin Obs Gynecol 15:639CrossRef

69.

Liu X, Ding J, Li Y, Hua K, Zhang X (2022) Comparison of two different methods for cervicovaginal reconstruction: a long-term follow-up. Int Urogynecol J. https://doi.org/10.1007/S00192-022-05327-X. (Published online Sep 16, 2022)CrossRefPubMedPubMedCentral

70.

Shen F, Zhang XY, Yin CY, Ding JX, Hua KQ (2016) Comparison of small intestinal submucosa graft with split-thickness skin graft for cervicovaginal reconstruction of congenital vaginal and cervical aplasia. Hum Reprod 31(11):2499–2505. https://doi.org/10.1093/HUMREP/DEW230CrossRefPubMed

71.

Mounir DM, Hernandez N, Gonzalez RR (2021) Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause. Urology 151:2–7. https://doi.org/10.1016/J.UROLOGY.2020.09.012CrossRefPubMed

72.

Katz A (2009) Interventions for sexuality after pelvic radiation therapy and gynecological cancer. Cancer J 15(1):45–47. https://doi.org/10.1097/PPO.0B013E31819585CFCrossRefPubMed

Title: Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer
Authors: Peace Orji
Helen Sun
Ilaha Isali
Spencer Bell
Nicholas Zaorsky
Kirtishri Mishra
Shubham Gupta
Andres Correa
Marc Smaldone
Adam Calaway
Rosalia Viterbo
Laura Bukavina
Publication date: 07-07-2023
Publisher: Springer Berlin Heidelberg
Keyword: Cystectomy
Published in: World Journal of Urology / Issue 7/2023
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04502-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2023

Improving clinical diagnostic accuracy and management of False penile fractures characterizing typical clinical presentation: a systematic review and meta-analysis

Correction: Adverse risk factors for salvage radiotherapy outcomes after radical prostatectomy in prostate cancer patients

Reply letter to: False discovery rate in laser studies

Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

Grade V renal trauma management: results from the multi-institutional genito-urinary trauma study